Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Irritable Bowel Syndrome, April 2024 Free Subscription Abstracts Retrieve all available abstracts of the following 127 articles: HTML format

Single Articles

1. WANG ZY, Ma DR, Li MJ, Liang YY, et al
   Association between irritable bowel syndrome and Parkinson's disease by Cohort study and Mendelian randomization analysis.
   NPJ Parkinsons Dis. 2024;10:70.
   PubMed    
   Abstract available
   
   

2. MING X, Gao S, Sun J, Zhang N, et al
   Regulation of the MCHergic Neural Circuit to Dorsal Raphe Nucleus on Emotion-Related Behaviors and Intestinal Dysfunction in Mice Model of Irritable Bowel Syndrome with Diarrhea.
   Neuroendocrinology. 2024 Mar 28. doi: 10.1159/000538582.
   PubMed    
   Abstract available
   
   

3. MIRON RJ, Estrin NE, Sculean A, Zhang Y, et al
   Understanding exososmes: Part 3-therapeutic + diagnostic potential in dentistry.
   Periodontol 2000. 2024 Mar 28. doi: 10.1111/prd.12557.
   PubMed    
   Abstract available
   
   

4. XIE X, He J, Xu S, Xu Z, et al
   Psychological factors may affect the quality of life in irritable bowel syndrome patients more than the gut itself? A multicenter cross-sectional study.
   JGH Open. 2024;8:e13045.
   PubMed    
   Abstract available
   
   

5. GARBATI P, Picco C, Magrassi R, Signorello P, et al
   Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.
   Pharmaceutics. 2024;16:431.
   PubMed    
   Abstract available
   
   

6. RURGO S, Marchili MR, Spina G, Roversi M, et al
   Prevalence of Rome IV Pediatric Diagnostic Questionnaire-Assessed Disorder of Gut-Brain Interaction, Psychopathological Comorbidities and Consumption of Ultra-Processed Food in Pediatric Anorexia Nervosa.
   Nutrients. 2024;16:817.
   PubMed    
   Abstract available
   
   

7. RAU S, Gregg A, Yaceczko S, Limketkai B, et al
   Prebiotics and Probiotics for Gastrointestinal Disorders.
   Nutrients. 2024;16:778.
   PubMed    
   Abstract available
   
   

8. CHEN J, Zhao T, Li H, Xu W, et al
   Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome.
   Int J Mol Sci. 2024;25:3514.
   PubMed    
   Abstract available
   
   

9. TABORI H, Barucha A, Zagoya C, Duckstein F, et al
   Scoring Abdominal Symptoms in People with Cystic Fibrosis.
   J Clin Med. 2024;13:1650.
   PubMed    
   Abstract available
   
   

10. XENOPOULOU E, Kontele I, Sergentanis TN, Grammatikopoulou MG, et al
    Biotics and Children's and Adolescents' Health: A Narrative Review.
    Children (Basel). 2024;11:329.
    PubMed    
    Abstract available
    
    

11. UBEDA F, Santander S, Luesma MJ
    Clinical Practice Guidelines for the Diagnosis and Management of Hereditary Fructose Intolerance.
    Diseases. 2024;12:44.
    PubMed    
    Abstract available
    
    

12. ZHOU S, Sun Q, Gao N, Hu Z, et al
    The Role of Inflammatory Biomarkers in Mediating the Effect of Inflammatory Bowel Disease on nonmalignant Digestive System Diseases: A Multivariable Mendelian Randomized Study.
    Can J Gastroenterol Hepatol. 2024;2024:1266139.
    PubMed    
    Abstract available
    
    

13. HIDAYAT AA, Waskito LA, Sugihartono T, Aftab H, et al
    Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective.
    Intest Res. 2024 Mar 26. doi: 10.5217/ir.2023.00199.
    PubMed    
    Abstract available
    
    

14. COSTA DVS, Pham NV, Loureiro AV, Yang SE, et al
    Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.
    Anaerobe. 2024 Mar 23:102837. doi: 10.1016/j.anaerobe.2024.102837.
    PubMed    
    Abstract available
    
    

15. ERFAN A, Aghaei A, Golparvar M
    Effectiveness of Group Emotional Schema Therapy on Psychological Distress, Severity and Frequency of Symptoms in Women with Irritable Bowel Syndrome.
    Adv Biomed Res. 2024;13:11.
    PubMed    
    Abstract available
    
    

16. POURKAZEM T, Ghazanfari A, Ahmadi R
    Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Therapy on the Cognitive Emotion Regulation in Patients with Irritable Bowel Syndrome.
    Middle East J Dig Dis. 2023;15:277-284.
    PubMed    
    Abstract available
    
    

17. BANERJEE A, Sarkhel S, Dhali GK, Paul I, et al
    A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome.
    Indian J Psychiatry. 2024;66:142-147.
    PubMed    
    Abstract available
    
    

18. CHEN M, Wei W, Li Y, Ge S, et al
    Cholestyramine alleviates bone and muscle loss in irritable bowel syndrome via regulating bile acid metabolism.
    Cell Prolif. 2024 Mar 25:e13638. doi: 10.1111/cpr.13638.
    PubMed    
    Abstract available
    
    

19. SUN Y, Nan H, Zhang C, Yang X, et al
    Genetic characteristics of Blastocystis sp. in cattle from Hebei Province, China.
    Microb Pathog. 2024;190:106629.
    PubMed    
    Abstract available
    
    

20. WU S, Yang Z, Liu S, Zhang Q, et al
    Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Clin Gastroenterol Hepatol. 2024 Mar 21:S1542-3565(24)00168.
    PubMed    
    Abstract available
    
    

21. OUYANG L, Liu T, He Y, He Y, et al
    A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D).
    J Ethnopharmacol. 2024;328:118050.
    PubMed    
    Abstract available
    
    

22. ZHAO Y, Zhan J, Sun C, Zhu S, et al
    Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndrome.
    Phytomedicine. 2024;129:155541.
    PubMed    
    Abstract available
    
    

23. CONLEY TE, Parkes M, Moss S, Probert C, et al
    Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?
    Clin Nutr. 2024;43:1079-1086.
    PubMed    
    Abstract available
    
    

24. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
    Multimorbidity of Allergic Diseases Is Associated With Functional Gastrointestinal Disorders in a Young Japanese Population.
    J Neurogastroenterol Motil. 2024;30:229-235.
    PubMed    
    Abstract available
    
    

25. NAKAYA K, Nakaya N, Kogure M, Hatanaka R, et al
    Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.
    J Neurogastroenterol Motil. 2024;30:208-219.
    PubMed    
    Abstract available
    
    

26. KIM NH, Choi HS, Lee MY, Seong H, et al
    The Effects of Fermented Rice Drink With Lactiplantibacillus plantarum JSA22 in Overweight Irritable Bowel Syndrome Patients: A Randomized, Double-blind, Placebo-controlled Study.
    J Neurogastroenterol Motil. 2024;30:194-207.
    PubMed    
    Abstract available
    
    

27. CHOI SI, Kim N, Nam RH, Jang JY, et al
    Sex Difference in the Effect of Bifidobacterium longum on Repeated Water Avoidance Stress-induced Gut Dysbiosis in Wistar Rats.
    J Cancer Prev. 2024;29:16-23.
    PubMed    
    Abstract available
    
    

28. HUONG BT, Hien NM, Dung NT, Quang DM, et al
    Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
    Med Arch. 2024;78:105-111.
    PubMed    
    Abstract available
    
    

29. WANG Y, Zhu J, Tang Y, Huang C, et al
    Association of periodontitis with gastrointestinal tract disorders: A bidirectional Mendelian randomization study.
    J Periodontol. 2024 Apr 2. doi: 10.1002/JPER.23-0560.
    PubMed    
    Abstract available
    
    

30. GELLER S, Levy S, Avitsur R
    Psychological distress in individuals with irritable bowel syndrome: the roles of body image and self-criticism.
    Health Psychol Behav Med. 2024;12:2334466.
    PubMed    
    Abstract available
    
    

31. CHEN W, Liao L, Huang Z, Lu Y, et al
    Corrigendum: Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats.
    Front Pharmacol. 2024;15:1394753.
    PubMed    
    Abstract available
    
    

32. HASSAN R, Singh P, Ballou S, Rangan V, et al
    Prevalence and determinants of postprandial diarrhea in a tertiary care center.
    Neurogastroenterol Motil. 2024 Apr 1:e14792. doi: 10.1111/nmo.14792.
    PubMed    
    Abstract available
    
    

33. VASAPOLLI R, Krikonas S, Macke L, Gravdal K, et al
    Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls.
    J Gastrointestin Liver Dis. 2024;33:30-36.
    PubMed    
    Abstract available
    
    

34. GUNASINGHA RMKD, Herrick-Reynolds K, Sanford JA, Radowsky J, et al
    Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation.
    BMJ Case Rep. 2024;17:e257148.
    PubMed    
    Abstract available
    
    

35. ROMETSCH C, Mansueto G, Maas Genannt Bermpohl F, Martin A, et al
    Prevalence of functional disorders across Europe: a systematic review and meta-analysis.
    Eur J Epidemiol. 2024 Mar 29. doi: 10.1007/s10654-024-01109.
    PubMed    
    Abstract available
    
    

36. ZUGASTI MURILLO A
    Diet low in fodmaps: fundamentals, evidence and controversies.
    Endocrinol Diabetes Nutr (Engl Ed). 2024;71:41-43.
    PubMed    
    
    
    

37. SULTAN N, Foyster M, Tonkovic M, Noon D, et al
    Presence and characteristics of disordered eating and orthorexia in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 12:e14797. doi: 10.1111/nmo.14797.
    PubMed    
    Abstract available
    
    

38. PEREYRA F, Bustos Fernandez LM, Schlottmann F, Zamora R, et al
    Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype.
    Neurogastroenterol Motil. 2024 Apr 12:e14796. doi: 10.1111/nmo.14796.
    PubMed    
    Abstract available
    
    

39. MATTIO N, Pradat P, Machon C, Mialon A, et al
    Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test.
    Neurogastroenterol Motil. 2024 Apr 12:e14801. doi: 10.1111/nmo.14801.
    PubMed    
    Abstract available
    
    

40. LI J, Fong DYT, Lok KYW, Wong JYH, et al
    Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study.
    J Glob Health. 2024;14:04068.
    PubMed    
    Abstract available
    
    

41. MORGAN RK, Wynn A, Hanisee MK
    Pneumatosis Cystoides Intestinalis Discovered During Exploratory Laparotomy.
    Cureus. 2024;16:e56032.
    PubMed    
    Abstract available
    
    

42. STALLMACH A, Quickert S, Puta C, Reuken PA, et al
    The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
    Front Immunol. 2024;15:1352744.
    PubMed    
    Abstract available
    
    

43. SHAFIEI F, Dehghani M, Lavasani FF, Manouchehri M, et al
    Intensive short-term dynamic psychotherapy for irritable bowel syndrome: a randomized controlled trial examining improvements in emotion regulation, defense mechanisms, quality of life, and IBS symptoms.
    Front Psychol. 2024;15:1293150.
    PubMed    
    Abstract available
    
    

44. ALSMADI MM, Abudaqqa AA, Idkaidek N, Qinna NA, et al
    The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling.
    AAPS PharmSciTech. 2024;25:86.
    PubMed    
    Abstract available
    
    

45. UTZ S, Bittel M, Langhorst J
    [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
    Z Gastroenterol. 2024 Apr 11. doi: 10.1055/a-2279-5045.
    PubMed    
    Abstract available
    
    

46. SELKER RJDM, Koppert TY, Houtveen JH, Geenen R, et al
    Psychological flexibility in somatic symptom and related disorders: A case control study.
    J Psychiatr Res. 2024;173:398-404.
    PubMed    
    Abstract available
    
    

47. LEMBO AJ, Edelstein S, Rosenbaum DP, Rooker C, et al
    Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publication.
    Therap Adv Gastroenterol. 2024;17:17562848241237196.
    PubMed    
    
    
    

48. WU H, Li J, Li F, Lun W, et al
    Causal association of gastroesophageal reflux disease on irritable bowel syndrome: a two-sample Mendelian randomization study.
    Front Genet. 2024;15:1328327.
    PubMed    
    Abstract available
    
    

49. KATSUMATA R, Kaburagi T, Hosokawa T, Manabe N, et al
    Different Food Preferences in Patients with Gastrointestinal Disorders.
    Intern Med. 2024 Apr 9. doi: 10.2169/internalmedicine.3433.
    PubMed    
    Abstract available
    
    

50. LI ZY, Mao YQ, Hua Q, Sun YH, et al
    Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome.
    World J Gastroenterol. 2024;30:1431-1449.
    PubMed    
    Abstract available
    
    

51. LAI T, Luo C, Yuan Y, Fang J, et al
    Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.
    Int J Chron Obstruct Pulmon Dis. 2024;19:873-886.
    PubMed    
    Abstract available
    
    

52. RODRIGUEZ-PALMA EJ, Huerta de la Cruz S, Islas-Espinoza AM, Castaneda-Corral G, et al
    Nociplastic pain mechanisms and toll-like receptors as promising targets for its management.
    Pain. 2024 Apr 5. doi: 10.1097/j.pain.0000000000003238.
    PubMed    
    Abstract available
    
    

53. MAJUMDAR D, Webb D, Parsons S, Selwan-Lewis EM, et al
    Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults.
    Curr Med Res Opin. 2024 Apr 10:1-13. doi: 10.1080/03007995.2024.2340720.
    PubMed    
    Abstract available
    
    

54. YAN XX, Zhang YL, Zhang YP, Yang YY, et al
    Diagnostic Accuracy of Computerized Bowel Sound Analysis with Non-Invasive Devices for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Chin Med Sci J. 2024 Apr 10. doi: 10.24920/004307.
    PubMed    
    Abstract available
    
    

55. LEE C, Rao S, Cabral HJ, Weber HC, et al
    Co-Morbidities of Irritable Bowel Syndrome in a Racially and Ethnically Diverse Population.
    J Clin Med. 2024;13:1482.
    PubMed    
    Abstract available
    
    

56. CHENG K, Lee C, Garniene R, Cabral H, et al
    Epidemiology of Irritable Bowel Syndrome in a Large Academic Safety-Net Hospital.
    J Clin Med. 2024;13:1314.
    PubMed    
    Abstract available
    
    

57. CHIARELLI M, De Simone M, Cioffi G, Cioffi U, et al
    New paradigm of oral rehydration in patients affected by irritable bowel syndrome with chronic diarrhea.
    World J Gastrointest Pharmacol Ther. 2024;15:90933.
    PubMed    
    Abstract available
    
    

58. HAN XY, Song XG, Ma WL, Fang M, et al
    Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs/Tryptase/PAR-2/MLCK pathway.
    Am J Transl Res. 2024;16:781-793.
    PubMed    
    Abstract available
    
    

59. CANTRELL C, Reid C, Walker CS, Stallkamp Tidd SJ, et al
    Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon.
    Front Neurol. 2024;15:1297964.
    PubMed    
    Abstract available
    
    

60. CHEN J, Ruan X, Fu T, Lu S, et al
    Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from mendelian randomization analysis.
    EBioMedicine. 2024;103:105110.
    PubMed    
    Abstract available
    
    

61. ZINK N
    [Not Available].
    MMW Fortschr Med. 2024;166:10.
    PubMed    
    
    
    

62. MA X, Huan H, Liu C, Hu H, et al
    Influence of ethnic origin on the clinical characteristics and intestinal flora of irritable bowel syndrome: a prospective study between Han and Tibetan patients.
    Front Med (Lausanne). 2024;11:1359962.
    PubMed    
    Abstract available
    
    

63. GOSTOLI S, Ferrara F, Quintavalle L, Tommasino S, et al
    Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD).
    BMC Psychol. 2024;12:211.
    PubMed    
    Abstract available
    
    

64. WYATT NJ, Watson H, Anderson CA, Kennedy NA, et al
    Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
    BMJ Open. 2024;14:e073639.
    PubMed    
    Abstract available
    
    

65. SRIVASTAVA S, Basak U, Naghibi M, Vijayakumar V, et al
    A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel
    Gut Microbes. 2024;16:2338322.
    PubMed    
    Abstract available
    
    

66. THOMAS BS, Perry D, Moe SS, Turgeon RD, et al
    Top studies of 2023 relevant to primary care: From the PEER team.
    Can Fam Physician. 2024;70:245-248.
    PubMed    
    Abstract available
    
    

67. MCKAY DM, Defaye M, Rajeev S, MacNaughton WK, et al
    Neuroimmunophysiology of the Gastrointestinal Tract.
    Am J Physiol Gastrointest Liver Physiol. 2024.
    PubMed    
    Abstract available
    
    

68. NAGAMINE T
    Amitriptyline at low dose for burning mouth syndrome.
    Oral Dis. 2024 Apr 15. doi: 10.1111/odi.14966.
    PubMed    
    
    
    

69. LUO Y, Luo CL, Meislin R, Yang E, et al
    Psychological comorbidities are more prevalent amongst pregnant and postpartum patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 15:e14800. doi: 10.1111/nmo.14800.
    PubMed    
    Abstract available
    
    

70. LACY BE, Gagnon-Sanschagrin P, Heimanson Z, Bungay R, et al
    Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.
    Adv Ther. 2024 Apr 15. doi: 10.1007/s12325-024-02832.
    PubMed    
    Abstract available
    
    

71. KOHLMEIER M, Baah E, Washko M, Adams K, et al
    Genotype-informed nutrition counselling in clinical practice.
    BMJ Nutr Prev Health. 2023;6:407-412.
    PubMed    
    
    
    

72. ALAWI Z, AlMakna W, Hassan F, Faisal M, et al
    Prevalence of Isolated Irritable Bowel Syndrome Among Adults in the Kingdom of Bahrain.
    Cureus. 2024;16:e56155.
    PubMed    
    Abstract available
    
    

73. SINGH P, Sayuk GS, Rosenbaum DP, Edelstein S, et al
    An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation.
    Clin Exp Gastroenterol. 2024;17:87-96.
    PubMed    
    Abstract available
    
    

74. CHANG X, Zhang H, Chen S
    Neural circuits regulating visceral pain.
    Commun Biol. 2024;7:457.
    PubMed    
    Abstract available
    
    

75. LUSETTI F, Schiepatti A, Scalvini D, Maimaris S, et al
    Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.
    Nutrients. 2024;16:1094.
    PubMed    
    Abstract available
    
    

76. MUSCOGIURI G, De Marco O, Di Lorenzo T, Amicone M, et al
    Diet and Physical Activity in Fabry Disease: A Narrative Review.
    Nutrients. 2024;16:1061.
    PubMed    
    Abstract available
    
    

77. MAQOUD F, Orlando A, Tricarico D, Antonacci M, et al
    Anti-Inflammatory Effects of a Novel Acetonitrile-Water Extract of Lens Culinaris against LPS-Induced Damage in Caco-2 Cells.
    Int J Mol Sci. 2024;25:3802.
    PubMed    
    Abstract available
    
    

78. KIM HY, Kim CE, Oh DR, Kim Y, et al
    Development and Validation of a High-Performance Liquid Chromatography Method to Quantify Marker Compounds in Lysimachia vulgaris var. davurica and Its Effects in Diarrhea-Predominant Irritable Bowel Syndrome.
    Molecules. 2024;29:1489.
    PubMed    
    Abstract available
    
    

79. SEIDITA A, Giuliano A, Soresi M, Chiavetta M, et al
    Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept.
    Intern Emerg Med. 2024 Apr 12. doi: 10.1007/s11739-024-03595.
    PubMed    
    Abstract available
    
    

80. ISHIOH M, Nozu T, Miyagishi S, Igarashi S, et al
    Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
    Biochem Pharmacol. 2024;224:116201.
    PubMed    
    Abstract available
    
    

81. DING W, Chen L, Xia J, Dong G, et al
    Causal relationships between gut microbrome and digestive system diseases: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37735.
    PubMed    
    Abstract available
    
    

82. HOU Y, Chang X, Liu N, Wang Z, et al
    Different acupuncture and moxibustion therapies in the treatment of IBS-D with anxiety and depression: A network meta-analysis.
    Medicine (Baltimore). 2024;103:e37982.
    PubMed    
    Abstract available
    
    

83. ZHANG J, Shi X, Wang Y
    Exploring causality in the association between gut microbiota and irritable bowel syndrome risk: a large Mendelian randomization study.
    Aging (Albany NY). 2024;16.
    PubMed    
    Abstract available
    
    

84. MOZAFFARI S, Nikfar S, Abdollahi M
    Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what's new?
    Expert Opin Drug Metab Toxicol. 2024 Apr 26. doi: 10.1080/17425255.2024.2348488.
    PubMed    
    Abstract available
    
    

85. JANATOLMAKAN M, Zobeiri M, Rezaeian S, Rostami S, et al
    Epidemiology of Celiac Disease in Western Iran during 2019-2021.
    Biomed Res Int. 2024;2024:1112812.
    PubMed    
    Abstract available
    
    

86. QING Q, Chen Y, Zheng DK, Sun ML, et al
    Systematic review with meta-analysis: effects of probiotic fungi on irritable bowel syndrome.
    Benef Microbes. 2023;14:303-315.
    PubMed    
    Abstract available
    
    

87. BOUTAHAR M, Er-Rami M, Belaouni M
    Prevalence of Blastocystis sp. among cooks in the region of Fez-Meknes (Morocco).
    Helminthologia. 2023;60:36-43.
    PubMed    
    Abstract available
    
    

88. KIM HJ, Kim HJ
    [Bile Acid Diarrhea].
    Korean J Gastroenterol. 2024;83:133-142.
    PubMed    
    Abstract available
    
    

89. SARKAWI M, Raja Ali RA, Abdul Wahab N, Abdul Rathi ND, et al
    A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
    Sci Rep. 2024;14:9478.
    PubMed    
    Abstract available
    
    

90. KNEZ E, Kadac-Czapska K, Grembecka M
    The importance of food quality, gut motility, and microbiome in SIBO development and treatment.
    Nutrition. 2024;124:112464.
    PubMed    
    Abstract available
    
    

91. CHAUDHARY M, Midha NK, Sukhadiya P, Kumar D, et al
    Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years.
    Cureus. 2024;16:e56828.
    PubMed    
    Abstract available
    
    

92. SIA T, Tanaka RO, Mousad A, Narayan AP, et al
    Fructose malabsorption and fructan malabsorption are associated in patients with irritable bowel syndrome.
    BMC Gastroenterol. 2024;24:143.
    PubMed    
    Abstract available
    
    

93. JANSSENDUIJGHUIJSEN L, van den Belt M, Rijnaarts I, Vos P, et al
    Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial.
    Eur J Nutr. 2024 Apr 23. doi: 10.1007/s00394-024-03398.
    PubMed    
    Abstract available
    
    

94. TAGHADDOS D, Saqib Z, Bai X, Bercik P, et al
    Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment.
    Dig Liver Dis. 2024 Apr 22:S1590-8658(24)00309-8. doi: 10.1016/j.dld.2024.
    PubMed    
    Abstract available
    
    

95. BASSOTTI G
    Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
    Expert Opin Investig Drugs. 2024 Apr 25:1-4. doi: 10.1080/13543784.2024.2347296.
    PubMed    
    
    
    

96. AHMED M, Pu A, Jencks K, Bishu S, et al
    Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.
    Neurogastroenterol Motil. 2024 Apr 23:e14809. doi: 10.1111/nmo.14809.
    PubMed    
    Abstract available
    
    

97. POKROTNIEKS J, Sitkin S
    He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 23:e14805. doi: 10.1111/nmo.14805.
    PubMed    
    Abstract available
    
    

98. KNOEDLER MA, Li S, Hirano S, Nakada SY, et al
    Higher Risk of Repeat Stone Surgery in Stone Formers with Concomitant Bowel Disease: Single Center Long Term Analysis.
    Urology. 2024 Apr 20:S0090-4295(24)00271-1. doi: 10.1016/j.urology.2024.
    PubMed    
    Abstract available
    
    

99. CHENG C, England E
    Nutrition: Chronic Disease Management.
    FP Essent. 2024;539:23-34.
    PubMed    
    Abstract available
    
    

100. QUIROGA-CASTANEDA PP, Berrios-Villegas I, Valladares-Garrido D, Vera-Ponce VJ, et al
     Irritable Bowel Syndrome in medical students at a Peruvian university: a cross-sectional study.
     Front Med (Lausanne). 2024;11:1341809.
     PubMed    
     Abstract available
     
     

101. ALMASAUDI AS
     A Review of the Efficacy of the Low Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Managing Gastrointestinal Symptoms Related to Cancer Treatment.
     Cureus. 2024;16:e56579.
     PubMed    
     Abstract available
     
     

102. TEIGE ES, Sortvik U, Lied GA
     A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.
     Clin Exp Gastroenterol. 2024;17:109-120.
     PubMed    
     Abstract available
     
     

103. ROBERTSON K, Hahn O, Robinson BG, Faruk AT, et al
     Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis.
     bioRxiv [Preprint]. 2024 Apr 12:2024.04.09.588619.
     PubMed    
     Abstract available
     
     

104. GUIDO V, Pontet Y, Lopez V, Olano C, et al
     Prevalence of irritable bowel syndrome and other functional gastrointestinal disorders in Uruguay.
     Rev Gastroenterol Mex (Engl Ed). 2024 Apr 20:S2255-534X(24)00033.
     PubMed    
     Abstract available
     
     

105. TAVARES LC, Lopera-Maya EA, Bonfiglio F, Zheng T, et al
     Rome III criteria capture higher irritable bowel syndrome SNP-heritability and highlight a novel genetic link with cardiovascular traits.
     Cell Mol Gastroenterol Hepatol. 2024 Apr 18:S2352-345X(24)00093.
     PubMed    
     Abstract available
     
     

106. GHOSHAL UC, Mustafa U, Goenka MK
     Managing irritable bowel syndrome: balancing diet and pharmacotherapy.
     Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00113.
     PubMed    
     
     
     

107. NYBACKA S, Tornblom H, Josefsson A, Hreinsson JP, et al
     A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARBIS): a single-centre, single-blind, randomised controlled trial.
     Lancet Gastroenterol Hepatol. 2024 Apr 18:S2468-1253(24)00045.
     PubMed    
     Abstract available
     
     

108. NOZU T, Arie H, Miyagishi S, Ishioh M, et al
     Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
     Int Immunopharmacol. 2024;133:112099.
     PubMed    
     Abstract available
     
     

109. WAEMONG A, Sattayachiti S, Cheaha D, Konthapakdee N, et al
     Effects of oral administration of ondansetron, a 5-HT(3) receptor antagonist, on anxiety-related behaviors and colonic hypercontractility in repeated stress-induced mice.
     Auton Neurosci. 2024;253:103178.
     PubMed    
     Abstract available
     
     

110. WESTPHAL K
     [Not Available].
     MMW Fortschr Med. 2024;166:15-16.
     PubMed    
     
     
     

111. ALIU A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, et al
     Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.
     Aliment Pharmacol Ther. 2024 Apr 8. doi: 10.1111/apt.17988.
     PubMed    
     Abstract available
     
     

112. BARRY HC
     Amitriptyline as Second-Line Therapy Improves Symptoms in Adults With Irritable Bowel Syndrome.
     Am Fam Physician. 2024;109:Online.
     PubMed    
     
     
     

113. CASH BD
     Congratulations. You Have Irritable Bowel Syndrome.
     Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002734.
     PubMed    
     
     
     

114. HANNA-JAIRALA I, Drossman DA
     CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN.
     Am J Gastroenterol. 2024 Apr 9. doi: 10.14309/ajg.0000000000002800.
     PubMed    
     Abstract available
     
     

115. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
     Gastroenterology/Hepatology: What You May Have Missed in 2023.
     Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
     PubMed    
     Abstract available
     
     

116. BRENNER DM, Sharma A, Rao SSC, Laitman AP, et al
     Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
     Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08330.
     PubMed    
     Abstract available
     
     

117. MATSUMURA T, Sonoda M, Okimoto K, Dao HV, et al
     Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
     Dig Dis Sci. 2024 Apr 15. doi: 10.1007/s10620-024-08411.
     PubMed    
     Abstract available
     
     

118. EL-SALHY M, Hatlebakk JG
     Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms.
     Dig Dis Sci. 2024;69:1336-1344.
     PubMed    
     Abstract available
     
     

119. VALVERDE DE MORALES HG, Wang HL, Garber K, Corces V, et al
     Coffee, Alcohol, and Artificial Sweeteners Have Temporal Associations with Gastrointestinal Symptoms.
     Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08457.
     PubMed    
     Abstract available
     
     

120. SADEGHIAN AM, Dashti F, Shariati B, Mokhtare M, et al
     The role of cognitive emotion regulation strategies in predicting the resilience, symptom severity, and quality of life of patients with irritable bowel syndrome.
     Clin Res Hepatol Gastroenterol. 2024 Apr 9:102341.
     PubMed    
     Abstract available
     
     

121. BABIKOW L, Fawcett TN, Pfeifer E, Berry S, et al
     Integrated Virtual Care for Irritable Bowel Syndrome: A Qualitative Study.
     Gastroenterol Nurs. 2024;47:85-91.
     PubMed    
     Abstract available
     
     

122. CHOGLE A, El-Chammas K, Santucci N, Grimm M, et al
     A multicenter registry study on percutaneous electrical nerve field stimulation for pediatric disorders of gut-brain interaction.
     J Pediatr Gastroenterol Nutr. 2024;78:817-826.
     PubMed    
     Abstract available
     
     

123. OPP J, Schurmann M, Jenke A, Job B, et al
     Drawing the abdominal pain: A powerful tool to distinguish between organic and functional abdominal pain.
     J Pediatr Gastroenterol Nutr. 2024;78:846-852.
     PubMed    
     Abstract available
     
     

124. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
     A comparison of Swedish IBS patients and general practitioners regarding viewpoints on IBS: a Q-methodology study.
     Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2328590.
     PubMed    
     Abstract available
     
     

125. EL-SALHY M, Gilja OH, Hatlebakk JG
     Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
     Scand J Gastroenterol. 2024;59:391-400.
     PubMed    
     Abstract available
     
     

126. DAI X, Liang M, Dai Y, Ding S, et al
     Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
     PLoS One. 2024;19:e0298963.
     PubMed    
     Abstract available
     
     

127. GUO Y, Lu Q, Yang XJ, He Y, et al
     Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
     PLoS One. 2024;19:e0299376.
     PubMed    
     Abstract available